Use of soluble epoxide hydrolase inhibitors in the treatment of inflammatory vascular diseases

Disclosed herein are compositions and methods for treating inflammatory vascular diseases. Examples of inflammatory vascular disease include, but are not limited to, in-stent stenosis, coronary arterial diseases (CAD), angina, acute myocardial infarction, acute coronary syndrome, chronic heart failu...

Full description

Saved in:
Bibliographic Details
Main Authors RUBANYI, GABOR M, ZHANG, LE-NING, WANG, YI-XIN
Format Patent
LanguageChinese
English
Published 16.03.2010
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Disclosed herein are compositions and methods for treating inflammatory vascular diseases. Examples of inflammatory vascular disease include, but are not limited to, in-stent stenosis, coronary arterial diseases (CAD), angina, acute myocardial infarction, acute coronary syndrome, chronic heart failure (CHF), peripheral arterial occlusive diseases (PAOD), critical limb ischemia (CLI), cardiac, kidney, liver and intestinal ischemia, renal failure, cardiac hypertrophy, atherosclerosis, abdominal aortic aneurysm, vasculitis, carotid artery stenosis.
AbstractList Disclosed herein are compositions and methods for treating inflammatory vascular diseases. Examples of inflammatory vascular disease include, but are not limited to, in-stent stenosis, coronary arterial diseases (CAD), angina, acute myocardial infarction, acute coronary syndrome, chronic heart failure (CHF), peripheral arterial occlusive diseases (PAOD), critical limb ischemia (CLI), cardiac, kidney, liver and intestinal ischemia, renal failure, cardiac hypertrophy, atherosclerosis, abdominal aortic aneurysm, vasculitis, carotid artery stenosis.
Author ZHANG, LE-NING
WANG, YI-XIN
RUBANYI, GABOR M
Author_xml – fullname: RUBANYI, GABOR M
– fullname: ZHANG, LE-NING
– fullname: WANG, YI-XIN
BookMark eNqNjU0KwjAUhLPQhX93eB5A8G_TpYjiASruLK_NhAbSpOSlYm9vBA8gs5iB-YaZq4kPHjP1vAsoGJLghtqB0Ie31aB21DE4zqX1ra1tClFypNSCUgSnDj59h9Ybx13HGRjpxdIMjiNpK8hjWaqpYSdY_Xyh1tdLeb5t8k8F6bmBR6rKx367yyqK4-nwD_MBzFE_HQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID TW201010994A
GroupedDBID EVB
ID FETCH-epo_espacenet_TW201010994A3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:38:12 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Chinese
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_TW201010994A3
Notes Application Number: TW200998128410
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100316&DB=EPODOC&CC=TW&NR=201010994A
ParticipantIDs epo_espacenet_TW201010994A
PublicationCentury 2000
PublicationDate 20100316
PublicationDateYYYYMMDD 2010-03-16
PublicationDate_xml – month: 03
  year: 2010
  text: 20100316
  day: 16
PublicationDecade 2010
PublicationYear 2010
RelatedCompanies ARETE THERAPEUTICS, INC
RelatedCompanies_xml – name: ARETE THERAPEUTICS, INC
Score 2.871027
Snippet Disclosed herein are compositions and methods for treating inflammatory vascular diseases. Examples of inflammatory vascular disease include, but are not...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Use of soluble epoxide hydrolase inhibitors in the treatment of inflammatory vascular diseases
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20100316&DB=EPODOC&locale=&CC=TW&NR=201010994A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvVNUaP4kZqYvS0ytnXjgRjZIMREIGYITxJaumxGB2Ezfvz1XusGvuhb00svaXvX3vV3dwW4qrnCCk1u6vbMYLrF647ecEyhu6aocdeWFrSq9tmj3aF1N7bHJXgucmFUndB3VRwRNYqjvmfqvF6sH7F8FVuZXrMYu-Y3naDpa7l3bEgZpZrfarYHfb_vaZ7XDEZa70HRJAhk3W7AJprRjtSG9mNLZqUsfl8pnT3YGiC3JNuH0ldUgR2v-HmtAtv3OeCNzVz30gN4GqaCzEMihYW9CIIMP3AGJPqcLdE_RWKcRDGL5fc52CRo2ZFVGLkciLKE2_-qYHVSRKCSHKFJD-Gy0w68ro58J6tVmQSj9ZzMIygn80QcA6EupRats3qIvhtrsKnDLe7YfFpzHWFMjROo_s2n-h_xFHZ_oHNTN-gZlLPlmzjHGzljF2opvwH6kZGQ
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8gGvFNUaP4VROzt0XGtm48ECMbBJWvmCE-SWgpYUYHYTN-_PVe6wBf9K3ppZe0vWvv-ru7AlwUXWGNTW7q9shgusVLjl52TKG7pihy15YWtKr22aaNnnX7aD9m4HmRC6PqhL6r4oioURz1PVHn9Wz1iOWr2Mr4koXYNb2qBxVfS71jQ8oo1fxqpdbt-B1P87xK0Nfa94omQSDreg3W0cR2pDbUHqoyK2X2-0qpb8NGF7lFyQ5kviZ5yHmLn9fysNlKAW9sproX78JTLxZkOiZSWNiLIMjwA2dAJp-jOfqnSAyjSchC-X0ONgladmQZRi4Hoizh9r8qWJ0sIlBJitDEe3BerwVeQ0e-g-WqDIL-ak7mPmSjaSQOgFCXUouWWGmMvhsrs6HDLe7YfFh0HWEMjUMo_M2n8B_xDHKNoNUcNG_ad0ew9QOjm7pBjyGbzN_ECd7OCTtVy_oN-w-Ugw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+soluble+epoxide+hydrolase+inhibitors+in+the+treatment+of+inflammatory+vascular+diseases&rft.inventor=RUBANYI%2C+GABOR+M&rft.inventor=ZHANG%2C+LE-NING&rft.inventor=WANG%2C+YI-XIN&rft.date=2010-03-16&rft.externalDBID=A&rft.externalDocID=TW201010994A